As an analog of glutamate-associated amino acids, KA has recently been reported to be associated with AD, especially with the production and deposition of Aβ (Ruan et al., 2019) and hyperphosphorylation of tau (Zheng et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.